Revumenib

60 interactions 3 explained in plain English
Also sold as: Revuforj
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Oxaliplatin Injection Alfuzosin Felbamate Lenvatinib Arsenic Trioxide Dofetilide
60 Major
All (60) Major (60)

Major

Revumenib Lenvatinib Lenvima An increased risk of QT interval prolongation Details Revumenib Levofloxacin Levaquin An increased risk of QT interval prolongation Details Revumenib Levofloxacin Injection Levaquin An increased risk of QT interval prolongation Details Revumenib Mefloquine Lariam® An increased risk of QT interval prolongation Details Revumenib Metronidazole Flagyl An increased risk of QT interval prolongation Details Revumenib Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Revumenib Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Revumenib Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Revumenib Mitapivat Aqvesme Reduced revumenib exposure and reduced efficacy of revumenib or an increased risk of QT prolongation associated with the M1 metabo... Details Revumenib Moxifloxacin Avelox An increased risk of QT interval prolongation Details Revumenib Moxifloxacin Injection Avelox An increased risk of QT interval prolongation Details Revumenib Moxifloxacin Ophthalmic Moxeza® An increased risk of QT interval prolongation Details Revumenib Nafarelin Nasal Spray Synarel An increased risk of QT interval prolongation Details Revumenib Nafcillin Injection Unipen® Injection Reduced revumenib exposure and reduced efficacy of revumenib or an increased risk of QT prolongation associated with the M1 metabo... Details Revumenib Octreotide Bynfezia An increased risk of QT interval prolongation Details Revumenib Octreotide Injection Bynfezia An increased risk of QT interval prolongation Details Revumenib Ofloxacin Floxin® An increased risk of QT interval prolongation Details Revumenib Ofloxacin Ophthalmic Ocuflox An increased risk of QT interval prolongation Details Revumenib Ofloxacin Otic Floxin® Otic An increased risk of QT interval prolongation Details Revumenib Oxaliplatin Injection Eloxatin® An increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.